LGT Fund Management Co Ltd.
Source: SEC Form 13F · as of Mar 2026LGT Fund Management Co Ltd. holds 22 biotech & pharma companies tracked by BioSniper, totaling $200.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$200.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 68,307 | $62.8M |
| JNJJOHNSON & JOHNSON | 112,310 | $27.5M |
| PFEPFIZER INC | 808,804 | $22.7M |
| AZNASTRAZENECA PLC | 103,991 | $20.2M |
| ABBVAbbVie Inc. | 48,331 | $10.5M |
| PMPhilip Morris International Inc | 44,065 | $7.3M |
| CAHCardinal Health Inc. | 25,500 | $5.4M |
| ALHCAlignment Healthcare Inc. | 272,700 | $4.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 17,494 | $4.7M |
| MRKMerck & Co., Inc. | 39,150 | $4.7M |
| ELVElevance Health Inc. | 14,277 | $4.2M |
| LQDALiquidia Corp | 110,250 | $4.2M |
| MCKMcKesson Corporation | 4,638 | $4.0M |
| ZTSZoetis Inc. | 33,434 | $4.0M |
| IMMXImmix Biopharma, Inc. | 416,594 | $3.8M |
| CORCencora Inc. | 11,760 | $3.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 5,063 | $2.3M |
| MEDPMedpace Holdings Inc. | 3,500 | $1.7M |
| IDXXIDEXX LABORATORIES INC /DE | 1,870 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 3,316 | $462K |
| BMYBRISTOL MYERS SQUIBB CO | 4,672 | $283K |
| REGNREGENERON PHARMACEUTICALS, INC. | 314 | $243K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.